Pharmacological inhibition or gene silencing of GFAT1 or GFAT2 blocks the proliferation of cancer cells and reduces their invasive capacity, which is consistent with a role for GFAT in tumor growth and malignancy [152,155]. The gene discussed is GFPT2; the disease is neoplasm.